Featured News
More News
SDRC researchers show a link between pancreatic alpha cells and diabetes
Pancreatic alpha cells from people with diabetes release excess amounts of glucagon, a hormone important in blood sugar control, in a new Stanford-developed mouse model of transplanted human islets.
Dr. Karl Deisseroth wins 2020 Heineken Prize for Medicine
Karl Deisseroth was awarded the prize for developing optogenetics, which enables remote manipulation of nerve cells using light, and hydrogel-tissue chemistry, which lets light and molecular probes travel through biological tissue
SDRC investigator, Dr. Michael Snyder, work towards a better understanding of exercise and fitness
A simple blood test may be able to determine how physically fit you are, according to a new study conducted by scientists at the Stanford University School of Medicine.
Got Oxygen? Dr. Avnesh Thakor's bioscaffolds make sure islets never go without.
Islet transplantation is an effective form of therapy for type 1 diabetics, however, lack of oxygen in transplanted islets decreases their survival and function over time. SDRC researcher Dr. Avnesh Thakor's group addressed the problem of oxygen accessibility by creating an innovative, transplantable bioscaffold for islets that makes its own oxygen. This work was featured on the back cover of Advanced Functional Materials and represents a milestone in having the potential to greatly improve the efficacy of islet transplantation therapy.
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.